Agenus
AGEN
#7782
Rank
$0.44 B
Marketcap
$9.93
Share price
0.40%
Change (1 day)
157.92%
Change (1 year)

Earnings for Agenus (AGEN)

Earnings in 2026 (TTM): $0.15 Billion USD

According to Agenus 's latest financial reports the company's current earnings are $0.13 Billion USD. In 2025 the company made an earning of $52.19 Million USD, an increase over its 2024 earnings that were of -$0.12 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agenus from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) $0.15 B189.4%
2025 $52.19 M-145.52%
2024 -$0.12 Billion-28.13%
2023 -$0.16 Billion-5.5%
2022 -$0.17 Billion-556.26%
2021 $36.99 M-130.37%
2020 -$0.13 Billion73.75%
2019 -$70.11 Million-48.74%
2018 -$0.14 Billion34.32%
2017 -$0.11 Billion-7.16%
2016 -$0.11 Billion26.55%
2015 -$86.67 Million110.24%
2014 -$41.23 Million49.12%
2013 -$27.65 Million
2011 -$19.09 Million-12.25%
2010 -$21.76 Million-21.41%
2009 -$27.68 Million-26.86%
2008 -$37.85 Million13.72%
2007 -$33.28 Million-33.4%
2006 -$49.97 Million-31.84%
2005 -$73.31 Million9.74%
2004 -$66.8 Million-0.8%
2003 -$67.35 Million17.37%
2002 -$57.38 Million37.83%
2001 -$41.63 Million55.99%
2000 -$26.69 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
$26.20 B 17,251.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$7.69 B 4,991.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$11.91 B 7,785.43%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
$7.88 B 5,123.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-$0.33 Billion-315.73%๐Ÿ‡บ๐Ÿ‡ธ USA